235 related articles for article (PubMed ID: 14962469)
1. The first minutes of reperfusion: a window of opportunity for cardioprotection.
Piper HM; Abdallah Y; Schäfer C
Cardiovasc Res; 2004 Feb; 61(3):365-71. PubMed ID: 14962469
[TBL] [Abstract][Full Text] [Related]
2. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].
Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E
Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337
[TBL] [Abstract][Full Text] [Related]
3. Preservation of mitochondrial function during ischemia as a possible mechanism for cardioprotection of diltiazem against ischemia/reperfusion injury.
Takeo S; Tanonaka K; Iwai T; Motegi K; Hirota Y
Biochem Pharmacol; 2004 Feb; 67(3):565-74. PubMed ID: 15037208
[TBL] [Abstract][Full Text] [Related]
4. Orphan targets for reperfusion injury.
Inserte J; Barrabés JA; Hernando V; Garcia-Dorado D
Cardiovasc Res; 2009 Jul; 83(2):169-78. PubMed ID: 19351740
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of mitochondrial, but not cytosolic, Ca2+ overload reduces myocardial injury induced by ischemia and reperfusion.
Cao CM; Yan WY; Liu J; Kam KW; Zhan SZ; Sham JS; Wong TM
Acta Pharmacol Sin; 2006 Jul; 27(7):911-8. PubMed ID: 16787576
[TBL] [Abstract][Full Text] [Related]
6. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
Ferdinandy P; Schulz R; Baxter GF
Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
[TBL] [Abstract][Full Text] [Related]
7. Myocardial protection against reperfusion injury: the cGMP pathway.
Garcia-Dorado D; Agulló L; Sartorio CL; Ruiz-Meana M
Thromb Haemost; 2009 Apr; 101(4):635-42. PubMed ID: 19350105
[TBL] [Abstract][Full Text] [Related]
8. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury.
Vinten-Johansen J
Cardiovasc Res; 2004 Feb; 61(3):481-97. PubMed ID: 14962479
[TBL] [Abstract][Full Text] [Related]
9. [Physiopathological basis of protection of the ischemic myocardium].
Lerch R; Benzi R
Schweiz Med Wochenschr; 1990 Oct; 120(42):1523-30. PubMed ID: 2237340
[TBL] [Abstract][Full Text] [Related]
10. Opening of mitochondrial permeability transition pore induces hypercontracture in Ca2+ overloaded cardiac myocytes.
Ruiz-Meana M; Abellán A; Miró-Casas E; Garcia-Dorado D
Basic Res Cardiol; 2007 Nov; 102(6):542-52. PubMed ID: 17891523
[TBL] [Abstract][Full Text] [Related]
11. A selective inhibitor of Na+/Ca2+ exchanger, SEA0400, preserves cardiac function and high-energy phosphates against ischemia/reperfusion injury.
Feng NC; Satoh H; Urushida T; Katoh H; Terada H; Watanabe Y; Hayashi H
J Cardiovasc Pharmacol; 2006 Feb; 47(2):263-70. PubMed ID: 16495765
[TBL] [Abstract][Full Text] [Related]
12. Intermittent high altitude hypoxia inhibits opening of mitochondrial permeability transition pores against reperfusion injury.
Zhu WZ; Xie Y; Chen L; Yang HT; Zhou ZN
J Mol Cell Cardiol; 2006 Jan; 40(1):96-106. PubMed ID: 16288778
[TBL] [Abstract][Full Text] [Related]
13. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
[TBL] [Abstract][Full Text] [Related]
14. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway.
Hausenloy DJ; Yellon DM
Cardiovasc Res; 2004 Feb; 61(3):448-60. PubMed ID: 14962476
[TBL] [Abstract][Full Text] [Related]
15. [Pathophysiology of myocardial reperfusion injury].
Piper HM; Kasseckert SA; Schlüter KD; Abdallah Y
Dtsch Med Wochenschr; 2008 Mar; 133(12):586-90. PubMed ID: 18335390
[TBL] [Abstract][Full Text] [Related]
16. Transient metabolic alkalosis during early reperfusion abolishes helium preconditioning against myocardial infarction: restoration of cardioprotection by cyclosporin A in rabbits.
Pagel PS; Krolikowski JG
Anesth Analg; 2009 Apr; 108(4):1076-82. PubMed ID: 19299764
[TBL] [Abstract][Full Text] [Related]
17. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning.
Halkos ME; Kerendi F; Corvera JS; Wang NP; Kin H; Payne CS; Sun HY; Guyton RA; Vinten-Johansen J; Zhao ZQ
Ann Thorac Surg; 2004 Sep; 78(3):961-9; discussion 969. PubMed ID: 15337028
[TBL] [Abstract][Full Text] [Related]
18. [Irreversible ischemic myocardial damage. Physiopathologic aspects of ischemia and myocardial revascularization].
Myrmel T
Tidsskr Nor Laegeforen; 1990 May; 110(13):1707-10. PubMed ID: 2195705
[TBL] [Abstract][Full Text] [Related]
19. Postconditioning: reduction of reperfusion-induced injury.
Zhao ZQ; Vinten-Johansen J
Cardiovasc Res; 2006 May; 70(2):200-11. PubMed ID: 16545349
[TBL] [Abstract][Full Text] [Related]
20. The mitochondrial permeability transition pore and the Ca2+-activated K+ channel contribute to the cardioprotection conferred by tumor necrosis factor-alpha.
Gao Q; Zhang SZ; Cao CM; Bruce IC; Xia Q
Cytokine; 2005 Dec; 32(5):199-205. PubMed ID: 16260145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
